A pharmacologic activator of endothelial KCa channels enhances coronary flow in the hearts of type 2 diabetic rats

Journal of Molecular and Cellular Cardiology

Volumn 72, Issue , 2014, Pages 364-373

  Mishra, Ramesh C ^a   Wulff, Heike ^b   Cole, William C ^a   Braun, Andrew P ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Coronary circulation; Endothelium; Type 2 diabetes; Vasodilation

Indexed keywords

ADENOSINE; BRADYKININ; CALCIUM CHANNEL; ION TRANSPORT AFFECTING AGENT; NAPHTHO[1,2 D]THIAZOLE 2 YLAMINE; NITROPRUSSIDE SODIUM; POTASSIUM CHANNEL; SKA 31; UNCLASSIFIED DRUG; BENZOTHIAZOLE DERIVATIVE; CALCIUM ACTIVATED POTASSIUM CHANNEL; NAPHTHO(1,2-D)THIAZOL-2-YLAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG POTENTIATION; ENDOTHELIAL DYSFUNCTION; HEART FUNCTION; HEART LEFT VENTRICLE PRESSURE; HEART PERFUSION; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; RAT; VASODILATATION; AGE; AGONISTS; ANIMAL; CORONARY ARTERY BLOOD FLOW; CORONARY BLOOD VESSEL; DIABETES MELLITUS, TYPE 2; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECTS; HEART; INFUSION PUMP; METABOLISM; ORGAN CULTURE TECHNIQUE; PATHOLOGY; PATHOPHYSIOLOGY; VASCULAR ENDOTHELIUM; WISTAR RAT;

ADENOSINE; AGE FACTORS; ANIMALS; BENZOTHIAZOLES; BRADYKININ; CORONARY CIRCULATION; CORONARY VESSELS; DIABETES MELLITUS, TYPE 2; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; HEART; INFUSION PUMPS; MALE; NITROPRUSSIDE; ORGAN CULTURE TECHNIQUES; POTASSIUM CHANNELS, CALCIUM-ACTIVATED; RATS; RATS, WISTAR;

EID: 84901320660     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2014.04.013     Document Type: Article

References (42)

1. Feigl E.O. Coronary physiology. Physiol Rev 1983, 63:1-205.
2. Antonio A., Rocha e Silva M. Coronary vasodilation produced by bradykinin on isolated mammalian heart. Circ Res 1962, 11:910-915.
3. Groves P., Kurz S., Just H., Drexler H. Role of endogenous bradykinin in human coronary vasomotor control. Circulation 1995, 92:3424-3430.
4. Liu Y., Gutterman D.D. Vascular control in humans: focus on the coronary microcirculation. Basic Res Cardiol 2009, 104:211-227.
5. Calles-Escandon J., Cipolla M. Diabetes and endothelial dysfunction: a clinical perspective. Endocr Rev 2001, 22:36-52.
6. Chen G., Cheung D.W. Characterization of acetylcholine-induced membrane hyperpolarization in endothelial cells. Circ Res 1992, 70:257-263.
7. + channels. Circulation 1999, 99:3132-3138.
8. + channels in normal and impaired EDHF-dilator responses - relevance to cardiovascular pathologies and drug discovery. Br J Pharmacol 2009, 157:509-526.
9. Busse R., Edwards G., Félétou M., Fleming I., Vanhoutte P.M., Weston A.H. EDHF: bringing the concepts together. TIPS 2002, 23:374-380.
10. + channels directly control agonist-evoked nitric oxide synthesis in human vascular endothelial cells. Am J Physiol Cell Physiol 2007, 293:C458-C467.
11. + channel blockers inhibits acetylcholine-evoked nitric oxide release in rat superior mesenteric artery. Br J Pharmacol 2006, 149:560-572.
12. Emerson G.G., Segal S.S. Electrical coupling between endothelial cells and smooth muscle cells in hamster feed arteries. Role in vasomotor control. Circ Res 2000, 87:474-479.
13. Garland C.J., Hiley C.R., Dora K.A. EDHF: spreading the influence of the endothelium. Br J Pharmacol 2011, 164:839-852.
14. Ca channels enhance agonist-evoked endothelial nitric oxide synthesis and arteriolar dilation. FASEB J 2009, 23:1138-1145.
15. Dalsgaard T., Kroigaard C., Misfeldt M., Simonsen U. Openers of small conductance calcium-activated potassium channels selectively enhance NO-mediated bradykinin vasodilatation in porcine retinal arterioles. Br J Pharmacol 2010, 160:1496-1508.
16. Ca channels, increases coronary flow in male and female rat hearts. Cardiovasc Res 2013, 97:339-348.
17. Östenson C.G. The Goto-Kakizaki rat. Animal Models of Diabetes 2007, 119-137. CRC Press, Boca Raton, FL.
18. El-Omar M.M., Yang Z.K., Phillips A.O., Shah A.M. Cardiac dysfunction in the Goto-Kakizaki rat. Basic Res Cardiol 2004, 99:133-141.
19. Cheng Z.J., Vaskonen T., Tikkanen I., Nurminen K., Ruskoaho H., Vapaatalo H., et al. Endothelial dysfunction and salt-sensitive hypertension in spontaneously diabetic Goto-Kakizaki rats. Hypertension 2001, 37:433-439.
20. D'Souza A., Howarth F.C., Yanni J., Dobrzynski H., Boyett M.R., Adeghate E., et al. Chronic effects of mild hypertension on left ventricle transcriptional profile and structural remodelling in the spontaneously type diabetic Goto-Kakizaki rat. Heart Fail Rev 2014, 19:65-74.
21. Portha B., Serradas P., Bailbé D., Suzuki K.I., Goto Y., Giroix M.H. β-cell insensitivity to glucose in the GK rat, a spontaneous nonobese model for Type II diabetes. Diabetes 1991, 40:486-491.
22. + channel, IKCa1: A potential immunosuppressant. Proc Natl Acad Sci U S A 2000, 97:8151-8156.
23. Sankaranarayanan A., Raman G., Busch C., Schultz T., Zimin P.I., Hoyer J., et al. Naphthol[1,2-d]thiazol-2-ylamine (SKA-31), a new activator of KCa2 and KCa3.1 potassium channels, potentiates the endothelium-derived hyperpolarizing factor response and lowers blood pressure. Mol Pharmacol 2009, 75:281-295.
24. Westerhof N., Boer C., Lamberts R.R., Sipkema P. Cross-talk between cardiac muscle and coronary vasculature. Physiol Rev 2006, 86:1263-1308.
25. Mombouli J.V., Bissiriou I., Agboton V., Vanhoutte P.M. Endothelium-derived hyperpolarizing factor: a key mediator of the vasodilator action of bradykinin. Immunopharmacology 1996, 33:46-50.
26. Berne R.M. The role of adenosine in the regulation of coronary blood flow. Circ Res 1980, 47:807-813.
27. Mehrke G., Pohl U., Daut J. Effects of vasoactive peptides on the membrane potential of cultured bovine aortic and guinea-pig coronary endothelium. J Physiol (Lond) 1991, 439:277-299.
28. Wulff H., Kolski-Andreaco A., Sankaranarayanan A., Sabatier J.M., Shakkottai V. Modulators of small- and intermediate-conductance calcium-activated potassium channels and their therapeutic indications. Curr Med Chem 2007, 14:1437-1457.
29. Brähler S., Kaistha A., Schmidt V.J., Wölfle S.E., Busch C., Kaistha B.P., et al. Genetic deficit of SK3 and IK1 channels disrupts the endothelium-derived hyperpolarizing factor vasodilator pathway and causes hypertension. Circulation 2009, 119:2323-2332.
30. + channels. Acta Physiol Scand 2011, 203:117-126.
31. + channel in porcine coronary artery endothelium: relevance to EDHF. Br J Pharmacol 2002, 135:1133-1143.
32. + channel in porcine coronary endothelium: relevance to EDHF. Br J Pharmacol 2002, 137:1346-1354.
33. Abebe W., Makujina S.R., Mustafa J. Adenosine receptor-mediated relaxation of porcine coronary artery in the presence and absence of endothelium. Am J Physiol Heart Circ Physiol 1994, 266:H2018-H2025.
34. Doughty J.M., Plane F., Langton P.D. Charybdotoxin and apamin block EDHF in rat mesenteric artery if selectively applied to endothelium. Am J Physiol 1999, 276:H1107-H1112.
35. Tang Y., Li G.D. Chronic exposure to high glucose impairs bradykinin-stimulated nitric oxide production by interfering with the phospholipase-C-implicated signalling pathway in endothelial cells: evidence for the involvement of protein kinase C. Diabetologia 2004, 47:2093-2104.
36. Ray C.J., Marshall J.M. The cellular mechanisms by which adenosine evokes release of nitric oxide from rat aortic endothelium. J Physiol (Lond) 2006, 570:85-96.
37. Ribeiro A.S., Fernandes V.S., Orensanz L.M., Martinez M.P., Recia P., Martinez-Saenz A., et al. Mechanisms involved in the adenosine-induced vasorelaxation to the pig prostatic small arteries. Purinergic Signal 2011, 7:413-425.
38. Brondum E., Kold-Petersen H., Simonsen U., Aalkjaer C. NS309 restores EDHF-type relaxation in mesenteric small arteries from type 2 diabetic ZDF rats. Br J Pharmacol 2010, 159:154-165.
39. Triggle C.R., Ding H. Endothelial dysfunction in diabetes: multiple targets for treatment. Pflugers Arch 2010, 459:977-994.
40. Segal S.S. Regulation of blood flow in the microcirculation. Microcirculation 2005, 12:33-45.
41. Shimokawa H. Primary endothelial dysfunction: atherosclerosis. J Mol Cell Cardiol 1999, 31:23-37.
42. Bi D., Toyama K., Lemaitre V., Takai J., Fan F., Jenkins D.P., et al. The intermediate conductance calcium-activated potassium channel KCa3.1 regulates vascular smooth muscle cell proliferation via controlling calcium-dependent signaling. J Biol Chem 2013, 288:15843-15853.